Trial Outcomes & Findings for Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens (NCT NCT05211739)
NCT ID: NCT05211739
Last Updated: 2023-06-27
Results Overview
Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.
COMPLETED
NA
76 participants
Day 1 and Day 30, each wear period (approximately 30 days)
2023-06-27
Participant Flow
Participants were recruited from 7 investigative sites located in the United States.
Of the 76 subjects enrolled in the study (i.e., signed informed consent), 2 subjects were exited prior to randomization as screen failures, and 1 randomized subject withdrew prior to exposure to the study lenses. This reporting group includes all randomized subjects/eyes (74/148).
Unit of analysis: eyes
Participant milestones
| Measure |
LID205255 Toric, Then Biofinity Toric
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
Biofinity Toric, Then LID205255 Toric
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
|---|---|---|
|
First Wear Period (Approx 30 Days)
STARTED
|
36 72
|
38 76
|
|
First Wear Period (Approx 30 Days)
Exposed to Study Lenses
|
35 70
|
38 76
|
|
First Wear Period (Approx 30 Days)
COMPLETED
|
35 70
|
36 72
|
|
First Wear Period (Approx 30 Days)
NOT COMPLETED
|
1 2
|
2 4
|
|
Second Wear Period (Approx 30 Days)
STARTED
|
35 70
|
36 72
|
|
Second Wear Period (Approx 30 Days)
COMPLETED
|
34 68
|
36 72
|
|
Second Wear Period (Approx 30 Days)
NOT COMPLETED
|
1 2
|
0 0
|
Reasons for withdrawal
| Measure |
LID205255 Toric, Then Biofinity Toric
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
Biofinity Toric, Then LID205255 Toric
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
|---|---|---|
|
First Wear Period (Approx 30 Days)
Adverse Event
|
0
|
1
|
|
First Wear Period (Approx 30 Days)
Withdrawal by Subject Prior to Exposure to the Study Lenses
|
1
|
0
|
|
First Wear Period (Approx 30 Days)
Withdrawal by Subject
|
0
|
1
|
|
Second Wear Period (Approx 30 Days)
Adverse Event
|
1
|
0
|
Baseline Characteristics
Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens
Baseline characteristics by cohort
| Measure |
LID205255 Toric, Then Biofinity Toric
n=36 Participants
Lehfilcon A toric contact lenses worn first, with comfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
Biofinity Toric, Then LID205255 Toric
n=38 Participants
Comfilcon A toric contact lenses worn first, with lehfilcon A toric contact lenses worn second, as randomized. Each product was worn bilaterally (in both eyes) during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
Total
n=74 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.9 year
STANDARD_DEVIATION 8.3 • n=93 Participants
|
35.8 year
STANDARD_DEVIATION 10.2 • n=4 Participants
|
34.4 year
STANDARD_DEVIATION 9.4 • n=27 Participants
|
|
Sex: Female, Male
Female
|
26 Participants
n=93 Participants
|
25 Participants
n=4 Participants
|
51 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=93 Participants
|
13 Participants
n=4 Participants
|
23 Participants
n=27 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=93 Participants
|
6 Participants
n=4 Participants
|
9 Participants
n=27 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
33 Participants
n=93 Participants
|
32 Participants
n=4 Participants
|
65 Participants
n=27 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
White
|
31 Participants
n=93 Participants
|
32 Participants
n=4 Participants
|
63 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
2 Participants
n=93 Participants
|
3 Participants
n=4 Participants
|
5 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Asian
|
3 Participants
n=93 Participants
|
2 Participants
n=4 Participants
|
5 Participants
n=27 Participants
|
|
Race/Ethnicity, Customized
Missing
|
0 Participants
n=93 Participants
|
1 Participants
n=4 Participants
|
1 Participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Day 1 and Day 30, each wear period (approximately 30 days)Population: All subjects exposed to any study lenses evaluated in this study, as randomized, with non-missing data at the respective visit.
Visual acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No inferences were pre-specified for the primary effectiveness endpoint; therefore, no hypothesis testing was performed.
Outcome measures
| Measure |
LID205255 Toric
n=142 eyes
Lehfilcon A toric contact lenses worn first or second, as randomized, in both eyes during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
Biofinity Toric
n=146 eyes
Comfilcon A toric contact lenses worn first or second, as randomized, in both eyes during waking hours for at least 5 days per week, with up to 10-12 hours wear time per day over a 30-day period. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
|
|---|---|---|
|
Distance Visual Acuity (VA) With Study Lenses
Day 1
|
-0.06 logMAR
Standard Deviation 0.09
|
-0.07 logMAR
Standard Deviation 0.09
|
|
Distance Visual Acuity (VA) With Study Lenses
Day 30
|
-0.08 logMAR
Standard Deviation 0.09
|
-0.06 logMAR
Standard Deviation 0.08
|
Adverse Events
Pretreatment
LID205255 Toric Ocular
LID205255 Toric Nonocular
Biofinity Toric Ocular
Biofinity Toric Nonocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Clinical Project Lead, CRD Vision Care
Alcon Research, LLC
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER